Sortina Pharma
PrivateLast Round
Seed
Jan 14, 2021
Company Overview
Sortina Pharma operates in Healthcare & Life Sciences and is based in Gothenburg. Its latest recorded funding round was a Seed round in January 2021.
Sortina Pharma is a biotechnology company that develops small molecule therapeutics targeting sortilin for the treatment of cancer and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sortina Pharma Comparables
Compare Sortina Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesper Bio ApS | 85% | |
| Draupnir Bio | 77% | |
| Teitur Trophics | 73% |
For institutional investors. Book with your work email.
Sortina Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sortina Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Seed |
| Eir Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2021
Led by Eir Ventures with participation from Vasa Angels I.
For institutional investors. Book with your work email.
Sortina Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sortina Pharma's valuation, stock price, and market status.
Is Sortina Pharma a public or private company?
Sortina Pharma is a private company.
What is the current stock price of Sortina Pharma?
Sortina Pharma is a private company, so its shares have no public market price. Caplight tracks Sortina Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sortina Pharma worth (valuation)?
Valuation information for Sortina Pharma is not publicly available.
Can I buy Sortina Pharma stock?
Sortina Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sortina Pharma's last funding round?
Sortina Pharma's most recent funding round was Seed on January 14, 2021.
Who are the main investors in Sortina Pharma?
Key investors in Sortina Pharma include Eir Ventures.
Will Sortina Pharma IPO soon?
No public IPO plans have been announced for Sortina Pharma.
How can I track Sortina Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Sortina Pharma's shares on secondary markets.